<DOC>
	<DOC>NCT02012998</DOC>
	<brief_summary>To evaluate the immune response to Hepatitis B virus in children who have been primed with HEXAVAC or INFANRIX HEXA 10 years ago.</brief_summary>
	<brief_title>Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Healthy child Child vaccinated with 3 doses of HEXAVAC or 3 doses of INFANRIX HEXA as infant Child vaccinated with the third dose of HEXAVAC or INFANRIX HEXA at least 10 years prior to challenge dose Receipt of more than 3 doses of any Hepatitis B containing vaccine History of clinical diagnosis of infection due to Hepatitis B History or current close contact with known carriers of Hepatitis B virus Prior known sensitivity or allergy to any component of HBVAXPRO Chronic illness / medical condition that could interfere with study conduct or completion Coagulation disorder that would contraindicate intramuscular injection Subject is pregnant Receipt of corticosteroids for more than 14 days in the 30 days prior to study Receipt of Immunoglobulins, blood or bloodderived products in the 3 months prior to study Planned participation in another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>